Table 5.
Overall (n=77 004) | Males (n=34 984) | Females (n=42 020) | ||||||||||
No of events | HR | 95% CI | P value | No of events | HR | 95% CI | P value | No of events | HR | 95% CI | P value | |
All-cause mortality | 2409 | 1416 | 993 | |||||||||
MDS | 0.95 | (0.91 to 0.98) | 0.005 | 0.93 | (0.88 to 0.98) | 0.004 | 0.97 | (0.91 to 1.03) | 0.33 | |||
Polygenic Risk Score | 1.00 | (0.96 to 1.04) | 0.91 | 1.02 | (0.97 to 1.07) | 0.51 | 0.98 | (0.92 to 1.05) | 0.58 | |||
CVD mortality | 364 | 263 | 101 | |||||||||
MDS | 0.97 | (0.88 to 1.08) | 0.60 | 0.94 | (0.84 to 1.06) | 0.32 | 1.07 | (0.88 to 1.29) | 0.49 | |||
Polygenic Risk Score | 1.08 | (0.98 to 1.20) | 0.12 | 1.10 | (0.98 to 1.25) | 0.11 | 1.03 | (0.85 to 1.25) | 0.79 | |||
Myocardial infarction | 1141 | 822 | 319 | |||||||||
MDS | 0.95 | (0.90 to 1.00) | 0.06 | 0.94 | (0.88 to 1.00) | 0.049 | 0.97 | (0.88 to 1.08) | 0.64 | |||
Polygenic Risk Score | 1.33 | (1.25 to 1.41) | <0.001 | 1.40 | (1.31 to 1.50) | <0.001 | 1.16 | (1.04 to 1.29) | 0.008 | |||
Stroke | 748 | 447 | 301 | |||||||||
MDS | 0.93 | (0.87 to 1.00) | 0.037 | 0.93 | (0.85 to 1.01) | 0.10 | 0.93 | (0.83 to 1.04) | 0.21 | |||
Polygenic Risk Score | 1.02 | (0.95 to 1.09) | 0.67 | 0.97 | (0.89 to 1.07) | 0.57 | 1.08 | (0.96 to 1.21) | 0.19 |
Models were adjusted for age (continuous), sex (when not used to stratify), deprivation (categorical), smoking status (categorical), physical activity (continuous), medication use (binary), family history of CVD (binary), energy intake (continuous) and the first eight principal components of ancestry and genotyping batch. All models include main effects of diet quality and polygenic risk score but not interaction terms.
CVD, cardiovascular disease.